Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$1.35 USD
-0.04 (-2.88%)
Updated May 24, 2024 03:59 PM ET
After-Market: $1.35 0.00 (0.00%) 5:50 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Iterum Therapeutics PLC [ITRM]
Reports for Purchase
Showing records 61 - 69 ( 69 total )
Company: Iterum Therapeutics PLC
Industry: Medical - Drugs
3Q19 Recap First Pivotal Readout in cIAI Around Year-End 2019; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Iterum Therapeutics PLC
Industry: Medical - Drugs
Company: Iterum Therapeutics PLC
Industry: Medical - Drugs
2Q Recap Major Near-Term Catalyst in Phase 3 Topline Expected 4Q19
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Iterum Therapeutics PLC
Industry: Medical - Drugs
Company: Iterum Therapeutics PLC
Industry: Medical - Drugs
We Highlight Several Antibiotics at the ASM Microbe 2019 Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Iterum Therapeutics PLC
Industry: Medical - Drugs
Not Just Another Antibiotic Company; Initiate Buy Ahead of Three Phase 3 Readouts
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E